HemoAware

HemoAware is a U.S.-based nonprofit organization focused on inherited bleeding disorders, especially hemophilia, von Willebrand disease, and related rare bleeding conditions. Rather than developing therapeutics, the organization appears to operate as a patient advocacy, education, and digital community platform serving people living with bleeding disorders. Public sources indicate it was founded in 2018 and has offered media, awareness, and technology-enabled support resources for the bleeding-disorder community. HemoAware also announced a merger with Hemo Times, a bleeding-disorder news website, expanding its content and outreach footprint. The organization is healthcare-related, but it is not a traditional biotech or pharmaceutical company with a drug development pipeline.